The DOI matches its Crossref record; 40 of the 42 references it cites were found in a registry or an index.
Quetiapine Nanoemulsion for Intranasal Drug Delivery: Evaluation of Brain-Targeting Efficiency
Abstract
To evaluate the possibility of improved drug delivery of quetiapine fumarate (QTP), a nanoemulsion system was developed for intranasal delivery. Effects of different HLBs of Emalex LWIS 10, PEG 400 and Transcutol P, as co-surfactants, were studied on isotropic region of pseudoternary-phase diagrams of nanoemulsion system composed of capmul MCM (CPM) as oil phase, Tween 80 as surfactant and water. Phase behaviour, globule size, transmission electron microscope (TEM) photographs and brain-targeting efficiency of quetiapine nanoemulsion were investigated. In vitro dissolution study of optimised nanoemulsion formulation, with mean diameter 144 ± 0.5 nm, showed more than twofold increase in drug release as compared with pure drug. According to results of in vivo tissue distribution study in Wistar rats, intranasal administration of QTP-loaded nanoemulsion had shorter T max compared with that of intravenous administration. Higher drug transport efficiency (DTE%) and direct nose-to-brain drug transport (DTP%) was achieved by nanoemulsion. The nanoemulsion system may be a promising strategy for brain-targeted delivery of QTP.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Brain distribution studies demonstrated that quetiapine is transported directly into the brain after the nasal administration of quetiapine NEs.”
From Nanoemulsions for “Nose-to-Brain” Drug Delivery (2019) · cites this paper as [70]
In the citing paper
“In vivo studies carried out on male Wistar rats following the nasal administration of NEs containing Transcutol P and propylene glycol showed shorter Tmax compared with that of intravenous administrations, as well as higher drug transport efficiency into the brain.”
From Nanoemulsions for “Nose-to-Brain” Drug Delivery (2019) · cites this paper as [70]
Citations
Cites
Microemulsion-based media as novel drug delivery systems
Lawrence, M. J., & Rees, G. D. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00103-4 · Cited by 2,044
Intranasal delivery to the central nervous system: Mechanisms and experimental considerations
Dhuria, S. V., Hanson, L. R., & Frey, W. H. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21924 · Cited by 1,239
Qian, C., & McClements, D. J. (2010) · Food Hydrocolloids · doi:10.1016/j.foodhyd.2010.09.017 · Cited by 930
Impact of Oil Type on Nanoemulsion Formation and Ostwald Ripening Stability
Wooster, T. J., Golding, M., & Sanguansri, P. (2008) · Langmuir · doi:10.1021/la801685v · Cited by 854
Development and bioavailability assessment of ramipril nanoemulsion formulation
Shafiq, S., Shakeel, F., Talegaonkar, S., Ahmad, F. J., Khar, R. K., & Ali, M. (2006) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.10.014 · Cited by 838
Freedman, R. (2003) · New England Journal of Medicine · doi:10.1056/nejmra035458 · Cited by 598
Yuan, Y., Gao, Y., Zhao, J., & Mao, L. (2007) · Food Research International · doi:10.1016/j.foodres.2007.09.006 · Cited by 506
Intranasal nanoemulsion based brain targeting drug delivery system of risperidone
Kumar, M., Misra, A., Babbar, A. K., Mishra, A. K., Mishra, P., & Pathak, K. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.03.029 · Cited by 435
The biopharmaceutical aspects of nasal mucoadhesive drug delivery
Ugwoke, M. I., Verbeke, N., & Kinget, R. (2001) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357011775145 · Cited by 355
Microemulsion formulation for enhanced absorption of poorly soluble drugs
Kawakami, K., Yoshikawa, T., Moroto, Y., Kanaoka, E., Takahashi, K. S., Nishihara, Y., & Masuda, K. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00049-4 · Cited by 306
Research works printed but not linked: 2
- Devarajan V, Ravichandran V. Nanoemulsions: as modified drug delivery tool. Int J Comprehensive Pharm. 2011;2(4):1–6.
- Gadiko C, Pamu P, Kilari EK. Effect of amiodarone on the pharmacodynamics of gliclazide in animal models. Int J Pharm Pharm Sci. 2013;5(4):290–3.
Cited by
Sorted by citations
Nanoemulsion: Concepts, development and applications in drug delivery
Singh, Y., Meher, J. G., Raval, K., Khan, F. A., Chaurasia, M., Jain, N. K., & Chourasia, M. K. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.03.008 · Cited by 1,358
Nanoemulsions for drug delivery
Wilson, R. J., Li, Y., Yang, G., & Zhao, C. (2021) · Particuology · doi:10.1016/j.partic.2021.05.009 · Cited by 410
Recent advances in carrier mediated nose-to-brain delivery of pharmaceutics
Bourganis, V., Kammona, O., Alexopoulos, A., & Kiparissides, C. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.05.009 · Cited by 357
Nanoemulsions for “Nose-to-Brain” Drug Delivery
Bonferoni, M. C., Rossi, S., Sandri, G., Ferrari, F., Gavini, E., Rassu, G., & Giunchedi, P. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11020084 · Cited by 269
Jeong, S., Jang, J.-H., & Lee, Y. (2022) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-022-00589-5 · Cited by 289
Chatterjee, B., Gorain, B., Mohananaidu, K., Sengupta, P., Mandal, U. K., & Choudhury, H. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.05.032 · Cited by 223
Nanotherapeutics for Nose-to-Brain Drug Delivery: An Approach to Bypass the Blood Brain Barrier
Lee, D., & Minko, T. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13122049 · Cited by 227
Nanoemulsions in Drug Delivery: Formulation to Medical Application
Tayeb, H. H., & Sainsbury, F. (2018) · Nanomedicine · doi:10.2217/nnm-2018-0088 · Cited by 190
Progress in nasal drug delivery systems
Laffleur, F., & Bauer, B. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120994 · Cited by 205
Intranasal Nanoemulsions for Direct Nose-to-Brain Delivery of Actives for CNS Disorders
Bahadur, S., Pardhi, D. M., Rautio, J., Rosenholm, J. M., & Pathak, K. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12121230 · Cited by 178
Zorkina, Y., Abramova, O. V., Ushakova, V. M., Morozova, A. Y., Zubkov, E. A., Valikhov, M. P., Melnikov, P., Majouga, A. G., & Chekhonin, V. P. (2020) · Molecules · doi:10.3390/molecules25225294 · Cited by 166
An update on the role of nanovehicles in nose-to-brain drug delivery
Feng, Y., He, H., Li, F., Lü, Y., Qi, J., & Wu, W. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.01.005 · Cited by 127
Brain targeting efficiency of antimigrain drug loaded mucoadhesive intranasal nanoemulsion
Abdou, E. M., Kandil, S. M., & Miniawy, H. M. F. E. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.07.030 · Cited by 124
Mirzaei, S., Mahabady, M. K., Zabolian, A., Abbaspour, A., Fallahzadeh, P., Noori, M., Hashemi, F., Hushmandi, K., Daneshi, S., Kumar, A. P., et al. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119368 · Cited by 115
Jazuli, I., Annu, Nabi, B., Moolakkadath, T., Alam, T., Baboota, S., & Ali, J. (2019) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2019.05.001 · Cited by 117
Abouhussein, D. M. N., Khattab, A., Bayoumi, N. A., Mahmoud, A. F., & Sakr, T. M. (2017) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2017.09.021 · Cited by 105
Nanoemulsions in CNS drug delivery: recent developments, impacts and challenges
Karami, Z., Zanjani, M. R. S., & Hamidi, M. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.03.021 · Cited by 102
Intranasal Nanoparticulate Systems as Alternative Route of Drug Delivery
Alshweiat, A., Ambrus, R., & Csóka, I. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190827151741 · Cited by 85
Drug targeting strategies into the brain for treating neurological diseases
Barnabas, W. (2019) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2018.10.015 · Cited by 70
Patharapankal, E. J., Ajiboye, A. L., Mattern, C., & Trivedi, V. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics16010066 · Cited by 75
Nose-to-brain delivery of antipsychotics using nanotechnology: a review
Tan, M. S. A., Parekh, H. S., Pandey, P. M., Siskind, D. J., & Falconer, J. R. (2020) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2020.1762563 · Cited by 68
Qizilbash, F. F., Ashhar, M. U., Zafar, A., Qamar, Z., Annu, Ali, J., Baboota, S., Ghoneim, M. M., Alshehri, S., & Ali, A. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14030656 · Cited by 61
Wu, Y., & Angelova, A. (2023) · Nanomaterials · doi:10.3390/nano13233004 · Cited by 58
Convolutions in the rendition of nose to brain therapeutics from bench to bedside: Feats & fallacies
Goel, H., Kalra, V., Verma, S. K., Dubey, S. K., & Tiwary, A. K. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.12.009 · Cited by 56
Direct nose to the brain nanomedicine delivery presents a formidable challenge
Yokel, R. A. (2021) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1767 · Cited by 53
Bahadur, S., Sachan, N., Harwansh, R. K., & Deshmukh, R. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200311131658 · Cited by 49
Susa, F., Arpicco, S., Pirri, C. F., & Limongi, T. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16070849 · Cited by 50
Zewail, M. B., El‐Gizawy, S. A., Asaad, G. F., Shabana, M. E.-A., & El‐Dakroury, W. A. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.123224 · Cited by 45
Ferreira, M. D., Duarte, J. G., Veiga, F., Paiva‐Santos, A. C., & Pires, P. C. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020678 · Cited by 48
Application of Intranasal Administration in the Delivery of Antidepressant Active Ingredients
Jin, Z., Han, Y., Zhang, D., Li, Z., Jing, Y., Hu, B., & Sun, S. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14102070 · Cited by 45
Nose-to-brain drug delivery for the treatment of CNS disease: New development and strategies
Du, L., Chen, L., Liu, F., Wang, W., & Huang, H. (2023) · International review of neurobiology · doi:10.1016/bs.irn.2023.05.014 · Cited by 43
Fahmy, S. A., Dawoud, A., Zeinelabdeen, Y. A., Kiriacos, C. J., Daniel, K. A., Eltahtawy, O., Abdelhalim, M. M., Braoudaki, M., & Youness, R. A. (2022) · Cancers · doi:10.3390/cancers14215244 · Cited by 42
Zaki, R. M., Alfadhel, M. M., Alossaimi, M. A., Elsawaf, L. A., Seshadri, V. D., Almurshedi, A. S., Yusif, R. M., & Said, M. (2022) · Pharmaceuticals · doi:10.3390/ph15080940 · Cited by 40
Nair, A. B., Chaudhary, S. A., Jacob, S., Patel, D., Shinu, P., Shah, H., Chaudhary, A., Al‐Dhubiab, B. E., Almuqbil, R. M., Alnaim, A., et al. (2023) · Gels · doi:10.3390/gels9020130 · Cited by 37
Advances in nasal drug delivery systems
Hussein, N., Omer, H. K., Elhissi, A. M. A., & Ahmed, W. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819712-7.00015-2 · Cited by 40
Bonaccorso, A., Ortis, A., Musumeci, T., Carbone, C., Hussain, M., Salvatore, V. D., Battiato, S., Pappalardo, F., & Pignatello, R. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s452316 · Cited by 35
Annu, Baboota, S., & Ali, J. (2021) · Polymer Bulletin · doi:10.1007/s00289-021-03598-w · Cited by 35
Sonawane, D., & Pokharkar, V. (2024) · AAPS PharmSciTech · doi:10.1208/s12249-024-02736-7 · Cited by 41
Self-citationAlexander, A., Agrawal, M., Chougule, M. B., Saraf, S., & Saraf, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817778-5.00009-9 · Cited by 31
Ahmed, B., Rizwanullah, M., Mir, S. R., Akhtar, M. S., & Amin, S. (2022) · Biomedical Materials · doi:10.1088/1748-605x/ac9267 · Cited by 32
Upadhyay, R. K., Ghosh, P., & Desavathu, M. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124866 · Cited by 31
Non-Invasive Techniques of Nose to Brain Delivery Using Nanoparticulate Carriers: Hopes and Hurdles
Butola, M., & Nainwal, N. (2024) · AAPS PharmSciTech · doi:10.1208/s12249-024-02946-z · Cited by 35
Wu, D., Salah, Y. A., Ngowi, E. E., Zhang, Y., Khattak, S., Khan, N. H., Wang, Y., Li, T., Guo, Z.-H., Wang, Y., et al. (2023) · iScience · doi:10.1016/j.isci.2023.107321 · Cited by 30
Review of Intranasal Active Pharmaceutical Ingredient Delivery Systems
Рафигович, С. Р., Fedotova, O., Uvarova, A., Гордиенко, М. Г., & Menshutina, N. V. (2024) · Pharmaceuticals · doi:10.3390/ph17091180 · Cited by 30
QbD Based Optimization of Curcumin Nanoemulsion: DoE and Cytotoxicity Studies
Acharya, S. D., Tamane, P., Khante, S. N., & Pokharkar, V. (2020) · Indian Journal of Pharmaceutical Education and Research · doi:10.5530/ijper.54.2.38 · Cited by 26
Self-citationAnalyzing Nanotheraputics-Based Approaches for the Management of Psychotic Disorders
Annu, Rehman, S., Md, S., Baboota, S., & Ali, J. (2019) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2019.08.027 · Cited by 25
Huang, C.-H., Wang, C., Zhang, W., Yang, T., Xia, M., Lei, X., Peng, Y., Wu, Y., Feng, J., Li, D., et al. (2022) · Molecules · doi:10.3390/molecules27217644 · Cited by 25
Meirinho, S., Rodrigues, M., Ferreira, C. L., Oliveira, R. C., Fortuna, A. C., Santos, A. O., Falcão, A. C., & Alves, G. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.121853 · Cited by 24
Wong, C. Y. J., Martinez, J., Al‐Salami, H., & Dass, C. R. (2018) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-018-1319-9 · Cited by 23
Grosso, C., Silva, A., Delerue-Matos, C. M., & Barroso, M. F. (2023) · Pharmaceuticals · doi:10.3390/ph16121721 · Cited by 26
Excipients Used for Modified Nasal Drug Delivery: A Mini-Review of the Recent Advances
Protopapa, C., Siamidi, A., Pavlou, P., & Vlachou, M. (2022) · Materials · doi:10.3390/ma15196547 · Cited by 26
NIOSOMES AS AN EMERGING FORMULATION TOOL FOR DRUG DELIVERY-A REVIEW
S., S. T., Mothilal, M., & Jaganathan, M. K. (2019) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2019v11i2.30534 · Cited by 21
Kadakia, E., Bottino, D. C., & Amiji, M. M. (2019) · Pharmaceutical Research · doi:10.1007/s11095-019-2610-y · Cited by 20
Nanocarriers for effective drug delivery
Theochari, I., Xenakis, A., & Papadimitriou, V. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816770-0.00019-8 · Cited by 22
Antipsychotics-Loaded Nanometric Emulsions for Brain Delivery
Pires, P. C., Paiva‐Santos, A. C., & Veiga, F. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14102174 · Cited by 18
Teixeira, F. C., Bruxel, F., Azambuja, J. H., Berenguer, A. M., Stefani, M. A., Sévigny, J., Spanevello, R. M., Battastini, A. M. O., Teixeira, H. F., & Braganhol, E. (2019) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2019.1705485 · Cited by 16
Kannavou, M., Karali, K., Κάτσιλα, Θ., Siapi, E., Marazioti, A., Klepetsanis, P. G., Calogeropoulou, T., Charalampopoulos, I., & Antimisiaris, S. G. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020419 · Cited by 16
Surface Modification of Nanoparticles to Oppose Uptake by the Mononuclear Phagocyte System
Parmar, K. R., & Patel, J. K. (2019) · Springer eBooks · doi:10.1007/978-3-030-06115-9_12 · Cited by 16
Tamane, P., Mahadik, K. R., & Pokharkar, V. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103105 · Cited by 15
Self-citationNose to Brain Drug Delivery: A Recent Update
Chatterjee, B. (2018) · Journal of Formulation Science & Bioavailability · doi:10.4172/2577-0543.1000105 · Cited by 14
Design and Fabrication of Brain-Targeted Drug Delivery
Soni, V., Pandey, V., Asati, S., Jain, P., & Tekade, R. K. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-817909-3.00014-5 · Cited by 14
Umar, Q.-U.-A., Khan, M. I., Ahmad, Z., Akhtar, M. F., Sohail, M. F., Madni, A., Erum, A., Ayesha, B. T., Ain, Q. U., & Mushtaq, A. (2024) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2024.08.011 · Cited by 12
Annu, Sartaj, A., Qamar, Z., Aldosari, E., Baboota, S., & Ali, J. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.106550 · Cited by 12
W/O/W Microemulsions for Nasal Delivery of Hydrophilic Compounds: A Preliminary Study
Cimino, C., Bonaccorso, A., Tomasello, B., Alberghina, G. A., Musumeci, T., Puglia, C., Pignatello, R., Marrazzo, A., & Carbone, C. (2024) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2024.01.013 · Cited by 11
An Updated Review on Nanoemulsion: Factory for Food and Drug Delivery
Kumar, V., Garg, V., Saini, N., Aggarwal, N., Kumar, H., Kumar, D., Chopra, H., Kamal, M. A., & Dureja, H. (2024) · Current Pharmaceutical Biotechnology · doi:10.2174/0113892010267771240211124950 · Cited by 11
Ansari, M. S., Ali, A., Rashid, M. A., Alhamhoom, Y., Sultana, N., Waheed, A., Alam, M. S., Aqil, M., & Sultana, Y. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105658 · Cited by 10
Nanotechnology-Based Drug Delivery System
Bhutta, Z. A., Shoaib, M., Kanwal, A., Ashar, A., Mahfooz, A., Huma, H., Ahmed, R., Ali, M., Kulyar, M. F., & Li, K. (2022) · Advances in bioinformatics and biomedical engineering book series · doi:10.4018/978-1-7998-8908-3.ch005 · Cited by 10
Taha, E., Nour, S. A. E.-K., Mamdouh, W., & Naguib, M. J. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124230 · Cited by 9
Revolutionizing nanomedicine: Expanding horizons of nanoemulsions in drug delivery and beyond
Kumar, M., Chauhan, N., Kumar, D., Mahmood, S., Chopra, S., & Bhatia, A. (2024) · Journal of Dispersion Science and Technology · doi:10.1080/01932691.2024.2369835 · Cited by 9
Nose-to-brain delivery of biologics and stem cells
Agrawal, M., Konwar, A. N., Alexander, A., & Borse, V. B. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822522-6.00015-1 · Cited by 9
Hao, M., Chu, J., Zhang, T., Yin, T., Gu, Y., Liang, W., Ji, W., Zhuang, J., Liu, Y., Gao, J., et al. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01736 · Cited by 8
Polymer–lipid hybrid nanostructures for drug delivery
Gusmão, L. A., & Tedesco, A. C. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85754-3.00003-4 · Cited by 8
Applications of innovative technologies to the delivery of antipsychotics
Bergonzi, M. C., Bilia, A. R., & Landucci, E. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.09.019 · Cited by 8
Phytomedicine nanoformulations for Parkinson's disease
Saji, C. V., Mohanakumar, K. P., & Shenoi, R. A. (2024) · Phytomedicine Plus · doi:10.1016/j.phyplu.2024.100704 · Cited by 7
Applications of nanoemulsions as drug delivery vehicle for phytoconstituents
Attama, A. A., Agbo, C. P., Onokala, O. B., Kenechukwu, F. C., Ugwueze, M. E., Mbah, C. C., Umeyor, C. E., Uronnachi, E., & Nnamani, P. O. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99527-6.00017-3 · Cited by 7
Applications of Polymeric Nanoparticle in Nose to Brain Drug Delivery
Sunena, S., Kumar, S., Sulekha, S., Tomar, D., Kumar, D., & Kishore, V. (2023) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2023.00988 · Cited by 6
Luo, Y., Che, X., Zheng, G., Liu, Z., Xie, D., & Wang, L. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.4c00582 · Cited by 6
Sadigh‐Eteghad, S., Shahi, S., Mahmoudi, J., Farjami, A., Bazmani, A., Naghili, B., Dizaj, S. M., & Salatin, S. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612828666220728092336 · Cited by 8
Katamreddy, J. D., Yalavarthi, P. R., Rao, D. S., Teja, S. S., & Battu, S. (2018) · International Journal of Pharmaceutical Investigation · doi:10.4103/jphi.jphi_9_18 · Cited by 6
Challenges in Targeting Nasal Passage and Nose-to-Brain Delivery via Nanoemulsions
Bahadur, S., & Pathak, K. (2023) · Springer eBooks · doi:10.1007/978-3-031-23112-4_5 · Cited by 6
Taher, S. S., & Al-Kinani, K. K. (2025) · OpenNano · doi:10.1016/j.onano.2025.100270 · Cited by 5
Chauhan, M., Mazumder, R., Rani, A., Mishra, R., & Pal, R. S. (2024) · Pharmaceutical Nanotechnology · doi:10.2174/0122117385325186240912110731 · Cited by 5
Pharmacokinetics of intranasal drugs, still a missed opportunity?
Sardu, M. L., & Poggesi, I. (2024) · Xenobiotica · doi:10.1080/00498254.2024.2349046 · Cited by 4
Alhowyan, A., Imran, M., Haque, A., & Kalam, M. A. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.106417 · Cited by 4
A nanochitosan-D-galactose formulation increases the accumulation of primaquine in the liver
Gomes, F., Ribeiro, A. C. D. M., Sanches, G. S., Borges, H. S., Takahashi, L. A. U., Daniel‐Ribeiro, C. T., Tedesco, A. C., Nascimento, J. W. L., & Carvalho, L. J. M. (2024) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00915-23 · Cited by 4
Sabale, V., Nikam, M., & Sabale, P. (2024) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-024-09859-1 · Cited by 4
Sawant, N. D., Tatke, P. A., & Desai, N. D. (2025) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5c00786 · Cited by 4
Application of nanoemulsion in pharmaceuticals industry
Jadhav, K., Singh, R., Ray, E., & Verma, R. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-90047-8.00011-x · Cited by 4
DESIGN, OPTIMIZATION AND EVALUATION OF INTRANASAL NANOTHERAPEUTIC OF ATYPICAL ANTIPSYCHOTIC DRUG
(2023) · European Chemical Bulletin · doi:10.48047/ecb/2023.12.si4.437 · Cited by 3
Sawant, N. D., Tatke, P. A., & Desai, N. D. (2024) · AAPS PharmSciTech · doi:10.1208/s12249-024-02964-x · Cited by 3
Effective Brain Targeting Using the Self-Emulsifying Drug Delivery Systems
Gawde, S., Bachhav, Y. G., & Kumar, M. S. (2026) · AAPS PharmSciTech · doi:10.1208/s12249-026-03398-3 · Cited by 2
Approaches for the delivery of anti-parkinsonian therapeutic agents via the intranasal route
Banyyounes, J., & Obeid, M. A. (2026) · Discover Neuroscience · doi:10.1186/s13064-026-00258-5 · Cited by 2
Sikder, A., Katarpawar, S. N., Phatale, V., Kumar, R., Vambhurkar, G. B., Wagh, S. S., Pandey, G., Kolipaka, T., Dikundwar, A. G., & Srivastava, S. (2026) · BioNanoScience · doi:10.1007/s12668-026-02757-5 · Cited by 2
Drug Delivery System and Technologies
Guo, W., Ding, P., Okoro, O. V., Sun, Y., Jiang, G., Shavandi, A., & Nie, L. (2025) · Smart nanomaterials technology · doi:10.1007/978-981-97-8086-0_3 · Cited by 2
An Emerging Prospective of Antipsychotics for Treating Neurodegenerative Disorders
Kumar, B., Sahoo, A., Singhal, M., Varshney, G., Halder, T., & Bali, V. (2025) · Current Pharmaceutical Design · doi:10.2174/0113816128344910241211112452 · Cited by 2
Kotha, A. K., Ghosh, S., Komanduri, N., Wang, R., Bhowmick, S., & Chougule, M. B. (2019) · Springer eBooks · doi:10.1007/978-981-13-3642-3_11 · Cited by 2
Alam, M. S., Ali, M. D., Ahmad, S., Banu, N., Ali, M. S., Alam, N., Ali, M. S., Ansari, M. S., Shamim, M., & Mujtaba, M. A. (2021) · PubMed · Cited by 2
Controlled Drug Delivery via the Nasal Route
Conway, B. R., & Ghori, M. U. (2021) · doi:10.1002/9781119769644.ch16 · Cited by 2
Intranasal carvacrol nanoemulsion: Stroke imaging and neuroprotective study
Mahajan, H. S., & Girnar, G. (2025) · ADMET & DMPK · doi:10.5599/admet.2967 · Cited by 1
Das, S., Sarkar, M., Bagchi, A., & Bahadur, S. (2026) · Drug Delivery and Translational Research · doi:10.1007/s13346-026-02054-4 · Cited by 1
Metadata
- Authors
- Boche, M., & Pokharkar, V.
- Affiliations
- Bharati Vidyapeeth (Deemed to be University) (IN)
- Corresponding author
- Pokharkar, Varsha
- ORCID
- Pokharkar, Varsha
- Venue
- AAPS PharmSciTech
- Published
- 2016-05-20
- Volume
- 18
- Issue
- 3
- Pages
- 686-696
- ISSN
- 1530-9932 (ISSN-L)
- OpenAlex
- W2405573244
- Cited by
- 109
- References
- 42
- Citations by year
- 2026: 7 · 2025: 6 · 2024: 23 · 2023: 14 · 2022: 14 · 2021: 11 · 2020: 9 · 2019: 14 · 2018: 8 · 2017: 3
- FWCI
- 4.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- AAPS PharmSciTech (publishedVersion)
- PubMed (publishedVersion)
- Funders
- All India Council for Technical Education
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- quetiapine, nanoemulsions, intranasal drug delivery, brain drug delivery, nose-to-brain transport, pseudo-ternary phase diagram, cosurfactants, globule size, drug release, tissue distribution, antipsychotic drug delivery
- MeSH terms
- Quetiapine Fumarate, Administration, Intranasal, Animals, Brain, Chemistry, Pharmaceutical, Emulsions, Male, Particle Size, Polysorbates, Solubility, Surface-Active Agents, Tissue Distribution, Drug Delivery Systems, Rats, Wistar, Rats, Nanoparticles, Drug Liberation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review